// App-Quantinova.ai

ABS199 : THE CLINICAL PHENOTYPE OF PATIENTS WITH NON‐SEVERE HEMOPHILIA A AND B

Researchers

Presenter

  • A.-F. Zwagemaker

Principal Investigators

  • F. R. Kloosterman

  • S. C. Gouw

  • C. N. Bagot

  • E. A. M. Beckers

  • S. Boyce

  • P. Brons

  • M. H. Cnossen

  • J. Eikenboom

  • F. W. G. Leebeek

  • C. Male

  • K. Meijer

  • L. Nieuwenhuizen

  • M. Coppens

  • J. G. Van der Bom

  • G. Castaman

  • K. Fijnvandraat

Medical Centers

  • Paediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands

  • Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom

  • Department of Medical Oncology, Maastricht University Medical Center, Maastricht, Netherlands

  • Haematology, University Hospital Southampton, Southampton, United Kingdom

  • Department of Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Internal Medicine, division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Urology, Medical University Vienna, Vienna, Austria

  • Department of Paediatrics, University Medical Center Groningen, Groningen

  • Department of Hematology, Maxima Medical Center Eindhoven, Eindhoven

  • Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam

  • Center for Clinical Transfusion Research, Sanquin‐Leiden University Medical Center, Leiden, Netherlands

  • Department of Oncology, Center for Bleeding Disorders, Careggi University Hospital, Florence, Italy

  • Molecular Cellular Hemostasis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Locations

  • Netherlands

  • United Kingdom

  • Austria

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • NCT03623295

Sponsors

  • N/A

Result

  • N/A